Risdiplam belongs to the SMN-C class of splice modulators: it increased full-length SMN protein in both severe and mild mouse models of SMA, with an increase in survival and improvement of motor phenotypes.41 The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.